Alnylam Pharmaceuticals
ALNY
#816
Rank
$29.78 B
Marketcap
$222.57
Share price
-3.72%
Change (1 day)
-51.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company